RKAGY OTC
RHÃN-KLINIKUM Aktiengesellschaft
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +7.4%
1Y: +10.7%
3Y: +21.6%
5Y: -12.5%
$8.16
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1.9B
+16.5% ▲
5Y CAGR: +6.5%
Gross Profit
$161M
-6.2% ▼
5Y CAGR: -29.7%
Operating Income
$4M
-91.2% ▼
5Y CAGR: -16.8%
Net Income
$33M
-23.6% ▼
5Y CAGR: +86.9%
EPS (Diluted)
$0.25
-26.9% ▼
5Y CAGR: +90.4%
EBITDA
$67M
-45.5% ▼
5Y CAGR: -2.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.4B | $1.5B | $1.6B | $1.9B |
| YoY Growth | +17.0% | -9.1% | +1.2% | +9.0% | +16.5% |
| Cost of Revenue | $430M | $447M | $1.3B | $1.4B | $1.7B |
| Gross Profit | $183M | $1000M | $149M | $172M | $161M |
| Gross Margin | 11.5% | 69.1% | 10.2% | 10.8% | 8.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $20M | $22M | $70M | $69M | $157M |
| Operating Expenses | $152M | $963M | $108M | $124M | $157M |
| Operating Income | $31M | $36M | $40M | $48M | $4M |
| Operating Margin | 1.9% | 2.5% | 2.8% | 3.0% | 0.2% |
| Interest Expense | $3M | $4M | $4M | $3M | $3M |
| Income Before Tax | $27M | $34M | $48M | $56M | $43M |
| Tax Expense | -$3M | $7M | $8M | $11M | $8M |
| Net Income | $28M | $25M | $39M | $43M | $33M |
| Net Margin | 1.8% | 1.7% | 2.6% | 2.7% | 1.8% |
| EPS (Diluted) | $0.21 | $0.19 | $0.29 | $0.34 | $0.25 |
| EBITDA | $100M | $98M | $117M | $122M | $67M |
| Shares Outstanding | 134M | 134M | 134M | 129M | 134M |